NovoCure: Q3 Earnings Insights

NovoCure NVCR reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

NovoCure beat estimated earnings by 3.85%, reporting an EPS of $-0.25 versus an estimate of $-0.26.

Revenue was down $2.61 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.08 which was followed by a 3.2% drop in the share price the next day.

Here's a look at NovoCure's past performance:

To track all earnings releases for NovoCure visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.